Welcome to our dedicated page for Axcelis Tech Ord SEC filings (Ticker: ACLS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Axcelis Technologies filings document the formal disclosures of a semiconductor equipment company focused on ion implantation systems and lifecycle support. Its Form 8-K reports cover operating results, material events, financial-condition updates, executive officer changes and annual-meeting voting results.
Proxy materials describe board elections, stockholder voting mechanics, independent auditor ratification, executive compensation and share ownership by directors, officers and significant holders. The filing record also includes disclosures related to material agreements, governance matters and capital-structure subjects tied to the company’s common stock and public-company reporting obligations.
ACLS director Jorge Titinger filed a Form 144 reporting an intended sale of 2,000 shares of Common Stock. The filing lists the broker as Morgan Stanley Smith Barney LLC and is dated 05/13/2026. The filing also discloses a prior sale of 1,000 shares on 02/20/2026 for $80,000.
Morgan Stanley Smith Barney LLC filed a Form 144 proposing the sale of 2,883 shares of Common Stock of ACLS. The filing lists restricted stock vesting entries tied to the issuer on 06/15/2023, 05/16/2023, 06/15/2022, and 09/15/2023 with quantities 1,766, 453, 166, and 498 respectively.
The form shows an aggregate figure of $463,730.55 and a separate numeric field 30,719,000 as presented on the form. The filing lists NASDAQ as the market and Morgan Stanley Smith Barney LLC as the filer at the New York Plaza address.
Morgan Stanley Smith Barney LLC Executive Financial Services submitted a Form 144 disclosure for ACLS reporting restricted stock vesting events under a registered plan. The filing lists specific vesting dates and the number of shares tied to each vesting event, identified as securities to be sold.
The entry shows vesting entries of 495 shares (02/28/2025), 794 shares (05/17/2024), 453 shares (05/16/2024) and 516 shares (05/15/2024). The filing names the broker/dealer as Morgan Stanley Smith Barney LLC Executive Financial Services and references NASDAQ.
Axcelis Technologies, Inc. reported weaker profitability for the quarter ended March 31, 2026. Revenue inched up to $198.9 million from $192.6 million, helped by stronger Aftermarket sales of $72.6 million, but systems revenue fell to $126.4 million.
Gross margin compressed to 40.5% from 46.1%, and net income dropped to $9.2 million from $28.6 million, with diluted EPS at $0.30. Higher operating expenses, including merger-related professional fees, contributed to the decline. Axcelis ended the quarter with $150.8 million in cash and cash equivalents plus significant investments, and generated $18.1 million in operating cash flow. The company’s pending stock-for-stock merger with Veeco remained on track for the second half of 2026, awaiting final regulatory approval in China.
Axcelis Technologies President and CEO Russell Low reported an open-market sale of 7,468 shares of Common Stock at $156.75 per share on May 6, 2026. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 11, 2025.
After this sale, Low directly holds 123,570 shares, including 83,480 shares issuable upon vesting of restricted stock units granted under the 2012 Equity Incentive Plan that remain subject to forfeiture. This filing reflects a planned, partial reduction while maintaining a significant ongoing equity position.
Axcelis Technologies reported Q1 2026 results with revenue of $198.956 million, up from $192.563 million in Q1 2025, driven by product revenue of $188.008 million and services revenue of $10.948 million.
GAAP gross margin declined to 40.5% from 46.1%, and operating margin fell to 4.0% from 15.1%. Net income dropped to $9.214 million, or $0.30 diluted EPS, compared with $28.579 million, or $0.88 diluted EPS, a year earlier. On a non-GAAP basis, diluted EPS was $0.72 versus $1.06.
Management highlighted strong demand in DRAM and HBM and ongoing strength in the CS&I business, but expects 2026 revenue to be relatively flat versus 2025. For Q2 2026, Axcelis guides to approximately $205 million in revenue, GAAP diluted EPS of $0.57 and non-GAAP diluted EPS of $0.90. The company ended the quarter with approximately $570 million of cash and continues to incur transaction and integration costs related to its planned merger with Veeco, expected to close in the second half of 2026.
FMR LLC (and Abigail P. Johnson) report beneficial ownership of 3,479,255.71 shares of Axcelis Technologies Inc. common stock, representing 11.3% of the class as shown on the Schedule 13G/A. The filing lists CUSIP 054540208 and references a power of attorney effective April 13, 2026.
The Schedule notes sole dispositive power of 3,479,255.71 shares and zero shared voting power. Exhibit references include a 13d-1(k)(1) agreement and an Exhibit 99 attachment. Signatures are by a duly authorized representative dated May 6, 2026.
Morgan Stanley Smith Barney LLC notified the sale of 7,468 shares of common stock by a holder via Form 144, with multiple 10b5-1 programmed dispositions listed. The filing lists three completed 10b5-1 sales by Russell Low dated 03/24/2026, 04/01/2026, and 05/01/2026, showing share counts of 1,244 shares each and dollar amounts per line. The filing records an aggregate numeric line showing 1,043,279.60 and a separate numeric field 30,718,815.
Axcelis Technologies, Inc. reported the results of its 2026 annual meeting of stockholders held in Beverly, Massachusetts. Of 30,729,970 common shares eligible to vote as of March 12, 2026, 27,730,608 shares, or 90.24%, were represented in person or by proxy.
Stockholders elected eight director nominees, each receiving between 88.16% and 98.73% of votes cast in favor. They also ratified the appointment of Ernst & Young LLP as independent registered public accounting firm for the year ending December 31, 2026, with 91.82% of votes cast in favor.
In an advisory vote on executive compensation for 2025, stockholders approved the pay of the named executive officers, with 90.56% of votes cast in favor, 2,381,859 votes against, and 51,140 abstentions, plus 2,436,760 broker non-votes.
Axcelis Technologies Inc ownership filing: FMR LLC reports beneficial ownership of 2,431,120.88 shares of Common Stock, representing 7.9% of the class as of 03/31/2026. The filing lists sole voting power of 2,421,135 and sole dispositive power of 2,431,120.88.